Target intelligence / Profile preview

Citrate cycle enzymes

Molecular classification
Enzyme (metabolic enzyme), Other
01

Overview

Citrate cycle enzymes" collectively refer to the suite of enzymes catalyzing the reactions of the citric acid (Krebs) cycle. These typically include (in order of the cycle): citrate synthase, aconitase, isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, succinyl-CoA synthetase, succinate dehydrogenase, fumarase, and malate dehydrogenase[7][1]. Each of these enzymes plays a vital role in the oxidative metabolism of carbohydrates, fats, and proteins, resulting in ATP (energy) production and generation of key metabolic intermediates[3][5]. The enzymes are tightly regulated by substrate concentrations, allosteric effectors, and feedback inhibition, reflecting the cycle's centrality in energy balance and biosynthesis[5][8]. Dysregulation of citrate cycle enzymes is implicated in metabolic disturbances seen in cancer, cardiovascular, and neurodegenerative diseases[6]. Targeting individual enzymes (such as isocitrate dehydrogenase in cancer) can have therapeutic value, but "citrate cycle enzymes" as a group is not a specific drug target. Key points: - This is not a single molecule but a functionally defined group[7]. - Enzymes individually are targets (e.g., isocitrate dehydrogenase) but the group is not a canonical "target" for drugs or biomarker panels as a whole[7]. - The entry should be flagged as "is_incorrect: true" because it is too broad and non-specific to serve as a proper molecular target for the intended structured data.

Other names
Citric acid cycle enzymesKrebs cycle enzymesTCA cycle enzymes
02

Biological functions

Energy productionOxidative metabolismIntermediary metabolism
03

Disease associations

CancerMetabolic disordersNeurodegenerative diseaseCardiovascular diseaseOther
04

Safety considerations

Systemic inhibition or activation affects energy production—potential for toxicity
05

Biomarkers

Altered enzyme activity or metabolite levels used in metabolic disease and some cancers

Beyond the preview

Go deeper on Citrate cycle enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Citrate cycle enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call